SCHDEULE 13D

Company

Lineage Cell Therapeutics, Inc.

Filed

September 27, 1996

Accession Number

0000899140-96-000479

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →